0001415889-23-012145.txt : 20230811
0001415889-23-012145.hdr.sgml : 20230811
20230811164806
ACCESSION NUMBER: 0001415889-23-012145
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230810
FILED AS OF DATE: 20230811
DATE AS OF CHANGE: 20230811
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: GOWEN MAXINE
CENTRAL INDEX KEY: 0001280044
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-31918
FILM NUMBER: 231164854
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Aceragen, Inc.
CENTRAL INDEX KEY: 0000861838
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 043072298
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 505 EAGLEVIEW BOULEVARD
STREET 2: SUITE 212
CITY: EXTON
STATE: PA
ZIP: 19341
BUSINESS PHONE: 4843481600
MAIL ADDRESS:
STREET 1: 505 EAGLEVIEW BOULEVARD
STREET 2: SUITE 212
CITY: EXTON
STATE: PA
ZIP: 19341
FORMER COMPANY:
FORMER CONFORMED NAME: IDERA PHARMACEUTICALS, INC.
DATE OF NAME CHANGE: 20050912
FORMER COMPANY:
FORMER CONFORMED NAME: HYBRIDON INC
DATE OF NAME CHANGE: 19951211
4
1
form4-08112023_080800.xml
X0508
4
2023-08-10
0000861838
Aceragen, Inc.
ACGN
0001280044
GOWEN MAXINE
C/O ACERAGEN, INC.
505 EAGLEVIEW BOULEVARD, SUITE 212
EXTON
PA
19341
true
false
false
false
0
Common Stock
2023-08-10
4
S
0
51
0.51
D
0
I
By Trust
Shares of common stock held in the name Brian Macdonald for Maxine Gowen Trust, for which the Reporting Person is a beneficiary and trustee.
/s/ Maxine Gowen
2023-08-11